** Eraloner (Eplerenone) 25 mg 20 Film-Coated Tablets.
Each Film-Coated Tablet contains:
Eplerenone 25 mg
** Therapeutic indications:
Eplerenone is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular (CV) mortality and morbidity in stable patients with left ventricular dysfunction (LVEF = 40%) and clinical evidence of heart failure after recent myocardial infarction (MI).
** Pharmacotherapeutic group:
aldosterone antagonists, ATC code: C03DA04
** Mechanism of action:
Eplerenone has relative selectivity in binding to recombinant human mineralocorticoid receptors compared to its binding to recombinant human glucocorticoid, progesterone and androgen receptors. Eplerenone prevents the binding of aldosterone, a key hormone in the renin-angiotensin-aldosterone-system (RAAS), which is involved in the regulation of blood pressure and the pathophysiology of CV disease.
** Store at temperature not exceeding 30 degrees C.
Keep out of reach of children.
** Manufactured by: Multi-Apex for pharmaceutical industries (Multi-Apex Pharma)-S.A.E.